Mirati - oncology?

[anonymous]

MELT DOWN ! Stock in free fall. WTF ! There will not be enough money to fund a competitive launch. Meeks sinks Mirati

 

[anonymous]

MELT DOWN ! Stock in free fall. WTF ! There will not be enough money to fund a competitive launch. Meeks sinks Mirati

Meek just doing his thing. Typical.

 

[anonymous]

Meek is an untrustworthy imbecile and the drug is a me-too at best. Anyone who joins this company should have their head examined.

 

[anonymous]

MELT DOWN ! Stock in free fall. WTF ! There will not be enough money to fund a competitive launch. Meeks sinks Mirati

Meek must go (MMG).

 

[anonymous]

How did he rise to CEO? He seems pretty dumb at best and his personality lacks any charisma. What was the board thinking?

Meek is an untrustworthy imbecile and the drug is a me-too at best. Anyone who joins this company should have their head examined.

 

[anonymous]

How did he rise to CEO? He seems pretty dumb at best and his personality lacks any charisma. What was the board thinking?

They weren’t thinking. He’s damaged goods.

 

[anonymous]

Mirati Skyrockets As Stock Price Rises ! Losers complain while Players make serious bank !!

 

[anonymous]

Mirati Skyrockets As Stock Price Rises ! Losers complain while Players make serious bank !!

What the f are you taking about? The stock is down 60% YTD.

 

[anonymous]

Mirati Skyrockets As Stock Price Rises ! Losers complain while Players make serious bank !!

What the f are you talking about? The stock is down 60% YTD.

 

[anonymous]

Mirati will simply fail. Oncology is about understanding and being able to communicate the clinical data. Our training is a joke! Primary care at its finest. Most of our upper management doesn't understand the data. Key accounts are the biggest joke. Idiots! Everyone patting each other on back will accomplish nothing. We will fail even if we get a drug to launch!

 

[anonymous]

Mirati will simply fail. Oncology is about understanding and being able to communicate the clinical data. Our training is a joke! Primary care at its finest. Most of our upper management doesn't understand the data. Key accounts are the biggest joke. Idiots! Everyone patting each other on back will accomplish nothing. We will fail even if we get a drug to launch!

Mel has failed at everything for at least the last ten years. Why should this be any different?

 

[anonymous]

Mel has failed at everything for at least the last ten years. Why should this be any different?

Meek has failed…

 

[anonymous]

You are caught up in the past. Last 5 days stock is on fire, we are making money, and will sell out next week with 42% return

 

[anonymous]

So true. People are not happy micromanaged and a mass exit is ongoing. People are interviewing all around.

Mirati will simply fail. Oncology is about understanding and being able to communicate the clinical data. Our training is a joke! Primary care at its finest. Most of our upper management doesn't understand the data. Key accounts are the biggest joke. Idiots! Everyone patting each other on back will accomplish nothing. We will fail even if we get a drug to launch!

 

[anonymous]

Meek is a two-faced fat bastard.

 

[anonymous]

Dude you are wrong ! Those are his two gigantic ass cheeks - pucker up and kiss kiss kiss

 

[anonymous]

You are caught up in the past. Last 5 days stock is on fire, we are making money, and will sell out next week with 42% return

Short sell again. I’m putting in more shorts at $41

 

[anonymous]

Short sell again. I’m putting in more shorts at $41

I’d peg it $30 as long as Meek stays on the scene.

 

[anonymous]

I’d peg for $30.

 

[anonymous]

So "equal efficacy" at the studied dose...yet Spira says the tox is due to the high dose...so do we really think if we lower...er I mean 'optimize' the dose to solve for the tox concerns the efficacy will stay the same? We are screwed, because really aren't patients and oncologists always looking for a new drug with similar efficacy with greater toxicity!!!

We tried, it didn't work out. It happens. Time to move on.

do you know oncology? Slightly lower dose with sustained treatment exposure would drive better efficacy. Mirati is far from being done.